Madrigal Pharmaceuticals, Inc. (MDGL) - Latest Market Data

Price & Market Data

Price: $510.3

Daily Change: +$13.23 / 2.59%

Daily Range: $490.1 - $511.1

Market Cap: $11,764,381,696

Daily Volume: 234,992

Performance Metrics

1 Week: 1.55%

1 Month: -2.93%

3 Months: 6.56%

6 Months: 4.29%

1 Year: 69.66%

YTD: -12.38%

About Madrigal Pharmaceuticals, Inc. (MDGL)

Daily market data for Madrigal Pharmaceuticals, Inc. (MDGL). Current price: 510.3, daily change: +$13.23 / 2.59%. Market cap: 11,764,381,696. Performance 1-week and 52-week.

Company Details

Employees: 915

Sector: Health technology

Industry: Pharmaceuticals: major

Country: United States

Details

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Selected stocks

BioAge Labs, Inc. (BIOA)

Atlanticus Holdings Corporation - 7.625% Series B Cumulative Perpetual Preferred Stock, no par value per share (ATLCP)

Nexstar Media Group, Inc. (NXST)

20/20 Biolabs, Inc. (AIDX)

OneWater Marine Inc. (ONEW)